Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02KEY
|
|||
Former ID |
DIB003164
|
|||
Drug Name |
SPP-676
|
|||
Indication | Hypertension [ICD-11: BA00-BA04; ICD-9: 401] | Discontinued in Phase 1 | [1] | |
Company |
Speedel Holding AG
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Angiotensinogenase renin (REN) | Target Info | Inhibitor | [2] |
KEGG Pathway | Renin-angiotensin system | |||
Pathwhiz Pathway | Angiotensin Metabolism | |||
Reactome | Metabolism of Angiotensinogen to Angiotensins | |||
WikiPathways | ACE Inhibitor Pathway | |||
Metabolism of Angiotensinogen to Angiotensins |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027192) | |||
REF 2 | New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon . Curr Hypertens Rep. 2015; 17(6): 42. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.